phenyl acetate has been researched along with Disease Exacerbation in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (10.42) | 18.2507 |
| 2000's | 22 (45.83) | 29.6817 |
| 2010's | 17 (35.42) | 24.3611 |
| 2020's | 4 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aspinall, RJ; Berg, CP; Boudes, P; Bowlus, CL; Choi, YJ; Dörffel, Y; Galambos, MR; Goel, A; Gordon, SC; Harrison, SA; Hirschfield, GM; Jones, DEJ; Kremer, AE; Levy, C; Mayo, MJ; McWherter, CA; Neff, GW; Sheridan, DA; Shiffman, ML; Stanca, CM; Steinberg, A; Swain, MG; Thuluvath, PJ; Vierling, JM | 1 |
| Johnson, B; Lubet, RA; Palen, K; Pan, J; Qiao, L; Sei, S; Shoemaker, RH; Wang, L; Wang, Y; You, M; Zhang, Q | 1 |
| Fan, GQ; Fu, X; Liang, QR; Luo, RG; Tang, Q; Zhao, J | 1 |
| Aydoğdu, A; Fidan, C | 1 |
| Abbott, SD; Blais, A; Cloutier, MP; Corpuz, R; Duceppe, JS; Felton, A; Gagnon, L; Gagnon, W; Geerts, L; Gervais, L; Grouix, B; Hébert, RL; Hince, K; Kennedy, CRJ; Laplante, SR; Laurin, P; Laverdure, A; Leblond, FA; Leduc, M; Letourneau, S; Ouboudinar, J; Quintela, VM; Sarra-Bournet, F; Simard, JC; Thibodeau, JF; Tremblay, M; Zacharie, B | 1 |
| Deerojanawong, J; Prapphal, N; Sritippayawan, S; Sunkonkit, K; Veeravikrom, M | 1 |
| Asae, KH; Koizumi, Y; Kojima, Y; Nagase, H; Ohta, K; Ro, S; Sugimoto, N; Ujino, M; Yamashita, N | 1 |
| Akhbari, M; Harris, KM; Kneale, D; Pike, KC | 2 |
| Arnaud, C; Arnol, N; Bäck, M; Belaïdi, E; Gautier-Veyret, E; Lévy, P; Pépin, JL; Perrin, M; Stanke-Labesque, F; Tamisier, R | 1 |
| Aravindan, N; Aravindan, S; Herman, TS; Natarajan, M; Somasundaram, DB; Somasundaram, ST | 1 |
| Boullerne, AI; Braun, D; Feinstein, DL; Pelligrino, D; Polak, PE; Sharp, A | 1 |
| Goldner, WS; Lyden, E; Poole, JA; Rorie, A | 1 |
| Bindels, LB; Blecker, C; Cani, PD; Daube, G; de los Reyes-Gavilán, CG; Delzenne, NM; Druart, C; François, E; Mahillon, J; Muccioli, GG; Neyrinck, AM; Richel, A; Salazar, N; Taminiau, B | 1 |
| Burns, L; Chai, X; Cheng, GS; Chien, JW; Flowers, MED; Ho, VT; Inamoto, Y; Jacobsohn, DA; Jagasia, M; Johnston, L; Lee, SJ; Martin, PJ; Mayer, S; Palmer, J; Pavletic, SZ; Pidala, J; Pusic, I; Storer, BE; Williams, KM | 1 |
| Bateman, ED; Goehring, UM; Richard, F; Watz, H | 1 |
| Muenz, LR; Qunibi, W | 1 |
| Cheng, S; Ge, S; Liu, D; Liu, X; Xu, G; Xu, J; Zhou, G | 1 |
| Cingi, C; Kayabasoglu, G; Nacar, A | 1 |
| Schluesener, HJ; Zhang, Z; Zhang, ZY | 1 |
| Gelb, MH; Rosenson, RS | 1 |
| Blesa, JM; Candel, VA | 1 |
| Chen, CC; Dai, ZK; Tsai, CW; Tsai, TC; Wu, JR; Wu, WF; Yang, CY | 1 |
| Berra, D; Canonica, GW; Chiodini, E; Colombo, F; Marogna, M; Massolo, A; Passalacqua, G; Spadolini, I; Zanon, P | 1 |
| Edelman, JM; Gern, JE; Grant, EN; Jia, G; Johnston, NW; Jones, CA; Sears, MR; Smugar, SS; Watkins, MW; Weiss, KB | 1 |
| Chirdjirapong, V; Jirapongsananuruk, O; Komoltri, C; Pajarn, P; Santadilog, S; Vichyanon, P; Visitsunthorn, N | 1 |
| Evenepoel, P; Meijers, B | 1 |
| Anderson, T; Blue, JW; Grégoire, J; Heinonen, T; Imus, J; L'Allier, PL; Lambert, J; Lespérance, J; Rodés, J; Tardif, JC | 1 |
| Armon, C | 1 |
| Brinker, T; Kondziella, D; Lüdemann, W; Qu, H; Sletvold, O; Sonnewald, U | 1 |
| Brune, K | 1 |
| Nolan, CR; Qunibi, WY | 1 |
| Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
| Boileau, C; Brunet, J; Laufer, S; Martel-Pelletier, J; Moreau, M; Pelletier, JP | 1 |
| Cohen, E; Grégoire, J; Guertin, MC; Heinonen, T; Ibrahim, R; Keller, PF; L'Allier, PL; Lavoie, MA; LeMay, M; Levesque, S; Tardif, JC | 1 |
| Allayee, H; Cohen, RI; Dixon, AE; Holbrook, JT; Irvin, CG; Lima, JJ; Shade, DM; Skloot, GS; Smith, LJ; Wise, RA | 1 |
| Berry, C; Grégoire, J; Ibrahim, R; L'Allier, PL; Lespérance, J; Levesque, S; Tardif, JC | 1 |
| Funao, K; Hayama, T; Kawahito, Y; Matsuyama, M; Nakatani, T; Sano, H; Takemoto, Y; Yoshimura, R | 1 |
| Martel-Pelletier, J; Pelletier, JP | 1 |
| Budoff, MJ; Gao, YL; Kessler, P; Mao, SS; Moustafa, M; Qunibi, W | 1 |
| Fujibayashi, Y; Okazawa, H; Takeuchi, H; Tsuchida, T; Tsujikawa, T | 1 |
| Badimon, JJ; Chew, DP; Corti, R; Fallon, JT; Fayad, ZA; Fuster, V; Helft, G; Worthley, MI; Worthley, SG; Zaman, AG | 1 |
| Budoff, M; Diaz-Buxo, JA; He, DY; Kessler, PD; Moustafa, M; Muenz, LR; Qunibi, W | 1 |
| Andrus, PK; Cutting, FB; Doble, A; Gurney, ME; Hall, ED; Taylor, CP; Zhai, P | 1 |
| Krause, BR; Nicolosi, RJ; Wilson, TA | 1 |
| Featherstone, JD; Fried, D; Kantorowitz, Z | 1 |
| Balzarini, C; Brigatti, M; Comazzi, F; Mazzini, L; Mora, G; Pastore, E; Pirali, I | 1 |
| Gerrity, RG; Kimsey, T; Nadler, JL; Natarajan, R | 1 |
8 review(s) available for phenyl acetate and Disease Exacerbation
| Article | Year |
|---|---|
Interventions for autumn exacerbations of asthma in children.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Behavior Therapy; Child; Chromones; Cyclopropanes; Disease Progression; Humans; Leukotriene Antagonists; Omalizumab; Quinolines; Randomized Controlled Trials as Topic; Seasons; Sulfides | 2018 |
Interventions for autumn exacerbations of asthma in children.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Disease Progression; Humans; Omalizumab; Quinolines; Seasons; Sulfides | 2018 |
Update on the medical treatment of allergic rhinitis.
Topics: Acetates; Adrenal Cortex Hormones; Allergens; Anti-Inflammatory Agents; Cyclopropanes; Disease Progression; Drug Administration Routes; Histamine Antagonists; Humans; Immunosuppression Therapy; Immunotherapy; Meta-Analysis as Topic; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Skin Tests; Sulfides | 2009 |
Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes.
Topics: Acetates; Animals; Arteriosclerosis; Disease Progression; Humans; Indoles; Inflammation; Keto Acids; Lipoproteins; Mice; Oxidative Stress; Phospholipases A2, Secretory; Phospholipids | 2009 |
How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?
Topics: Acetates; Amines; Amyotrophic Lateral Sclerosis; Anticonvulsants; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Neuroprotective Agents; Quality of Life; Riluzole; Sickness Impact Profile | 1999 |
Safety of anti-inflammatory treatment--new ways of thinking.
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Gastrointestinal Diseases; Humans; Isoenzymes; Membrane Proteins; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrroles | 2004 |
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Calcinosis; Calcium Compounds; Coronary Vessels; Disease Progression; Dose-Response Relationship, Drug; Epoxy Compounds; Humans; Kidney Failure, Chronic; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; United States | 2005 |
DMOAD developments: present and future.
Topics: Acetates; Anthraquinones; Antirheumatic Agents; Chondroitin; Clinical Trials as Topic; Diphosphonates; Disease Progression; Doxycycline; Glucosamine; Humans; Hyaluronic Acid; Matrix Metalloproteinase Inhibitors; Osteoarthritis; Pyrroles; Risk Factors | 2007 |
14 trial(s) available for phenyl acetate and Disease Exacerbation
| Article | Year |
|---|---|
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
Topics: Acetates; Adult; Alkaline Phosphatase; Disease Progression; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid | 2022 |
Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study.
Topics: Acetates; Adult; Aged; Cetirizine; Cholecalciferol; Chronic Disease; Cyclopropanes; Dietary Supplements; Disease Progression; Female; Humans; Male; Middle Aged; Prospective Studies; Quinolines; Ranitidine; Sulfides; Urticaria; Young Adult | 2014 |
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents; Azithromycin; Bronchiolitis Obliterans; Cyclopropanes; Disease Progression; Fluticasone; Forced Expiratory Volume; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lung; Male; Middle Aged; Quality of Life; Quinolines; Sulfides; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2016 |
Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
Topics: Acetates; Aged; Aged, 80 and over; Aminopyridines; Anti-Asthmatic Agents; Asthma; Benzamides; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Risk Factors; Severity of Illness Index; Spirometry; Sulfides; Treatment Outcome | 2016 |
Montelukast as monotherapy in children with mild persistent asthma.
Topics: Acetates; Adolescent; Asthma; Child; Child, Preschool; Cyclopropanes; Disease Progression; Female; Humans; Leukotriene Antagonists; Male; Peak Expiratory Flow Rate; Prospective Studies; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome | 2009 |
Randomized open comparison of montelukast and sublingual immunotherapy as add-on treatment in moderate persistent asthma due to birch pollen.
Topics: Acetates; Administration, Sublingual; Adolescent; Adult; Aged; Antigens, Plant; Asthma; Betula; Cell Count; Cyclopropanes; Desensitization, Immunologic; Disease Progression; Eosinophilia; Female; Follow-Up Studies; Humans; Leukotriene Antagonists; Male; Middle Aged; Nasal Obstruction; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2010 |
The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year.
Topics: Acetates; Adolescent; Anti-Allergic Agents; Asthma; Child; Clinical Protocols; Cyclopropanes; Disease Progression; Female; Humans; Male; Periodicity; Quinolines; Schools; Seasons; Sulfides; Treatment Outcome | 2010 |
The effect of montelukast on bronchial hyperreactivity and lung function in asthmatic children aged 6-13 years.
Topics: Acetates; Adolescent; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Child; Cyclopropanes; Disease Progression; Female; Humans; Leukotriene Antagonists; Lung; Male; Quinolines; Respiratory Function Tests; Sulfides; Thailand; Treatment Outcome | 2011 |
Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial.
Topics: Acetamides; Acetates; Adult; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Male; Research Design; Statistics as Topic; Sulfonamides; Sulfonic Acids; Ultrasonography | 2002 |
Effect of obesity on clinical presentation and response to treatment in asthma.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Cytokines; Disease Progression; Double-Blind Method; Female; Forced Expiratory Volume; Gastroesophageal Reflux; Humans; Male; Middle Aged; Obesity; Quinolines; Risk Factors; Sleep Wake Disorders; Sulfides; Theophylline; Treatment Outcome; Vital Capacity | 2006 |
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Topics: Acetates; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Reproducibility of Results; Sevelamer; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Carbon Radioisotopes; Cerebral Cortex; Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
Topics: Acetates; Anticholesteremic Agents; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Female; Heptanoic Acids; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Renal Dialysis; Sevelamer; Time Factors | 2008 |
The natural history and the effects of gabapentin in amyotrophic lateral sclerosis.
Topics: Acetates; Administration, Oral; Adult; Aged; Amines; Amyotrophic Lateral Sclerosis; Cyclohexanecarboxylic Acids; Disability Evaluation; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Prognosis; Survival Analysis; Survival Rate | 1998 |
26 other study(ies) available for phenyl acetate and Disease Exacerbation
| Article | Year |
|---|---|
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator.
Topics: Acetamides; Acetates; Amino Acid Sequence; Animals; Cancer Vaccines; Cholesterol; Disease Progression; Lung Neoplasms; Mice; Proto-Oncogene Proteins p21(ras); Sulfonamides; Sulfonic Acids; T-Lymphocytes, Regulatory; Vaccines, Subunit | 2019 |
Intratumoral inorganic phosphate deprivation: A new anticancer strategy?
Topics: Acetates; Animals; Antineoplastic Agents; Carcinogenesis; Chelating Agents; Chemoembolization, Therapeutic; Colorectal Neoplasms; Disease Progression; Hyperphosphatemia; Lanthanum; Liver Neoplasms; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Phosphates; Rabbits | 2020 |
As a potential treatment of COVID-19: Montelukast.
Topics: Acetates; Anti-Inflammatory Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclopropanes; Cytokines; Disease Progression; Humans; Inflammation; Oxidative Stress; Pandemics; Pneumonia, Viral; Quinolines; Receptors, Leukotriene; SARS-CoV-2; Sulfides | 2020 |
Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver disease.
Topics: Acetates; Animals; Binding, Competitive; Biosensing Techniques; Cholesterol; Disease Models, Animal; Disease Progression; Drug Discovery; Fatty Acids; Female; Glucose; Glucose Tolerance Test; HEK293 Cells; Homeostasis; Humans; Ligands; Magnetic Resonance Spectroscopy; Male; Metabolomics; Mice; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Oxygen; Plasmids; Protein Binding; Receptors, G-Protein-Coupled | 2020 |
Urinary cysteinyl leukotriene E4 level and therapeutic response to montelukast in children with mild obstructive sleep apnea.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Biomarkers, Pharmacological; Child; Child, Preschool; Creatinine; Cyclopropanes; Disease Progression; Female; Humans; Leukotriene E4; Male; Predictive Value of Tests; Prognosis; Quinolines; Sleep Apnea, Obstructive; Sulfides | 2017 |
Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
Topics: Acetates; Alum Compounds; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Cytokines; Disease Models, Animal; Disease Progression; Eosinophils; Immunization; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Male; Mice; Ovalbumin; Poly I-C; Quinolines; Respiratory Hypersensitivity; RNA, Double-Stranded; RNA, Viral; Sulfides | 2017 |
Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome.
Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Adult; Animals; Arachidonate 5-Lipoxygenase; Atherosclerosis; Case-Control Studies; Cyclopropanes; Cysteine; Disease Models, Animal; Disease Progression; Female; Humans; Leukotriene Antagonists; Leukotriene E4; Leukotrienes; Male; Mice, Knockout, ApoE; Middle Aged; Plaque, Atherosclerotic; Quinolines; Receptors, Leukotriene; Risk Factors; Signal Transduction; Sleep Apnea, Obstructive; Sulfides | 2018 |
Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols.
Topics: Acetates; Animals; Apoptosis; Aquatic Organisms; Carcinogenesis; Cell Line, Tumor; Cell Survival; Disease Progression; Humans; Mice, Nude; Neoplasm Proteins; Pancreatic Neoplasms; Polyphenols; Seaweed | 2019 |
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
Topics: Acetates; Amino Acid Sequence; Animals; Autoantigens; Chemical Fractionation; Disease Progression; Dose-Response Relationship, Immunologic; Drug Contamination; Encephalomyelitis, Autoimmune, Experimental; Female; Immunization; Immunization, Secondary; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Severity of Illness Index; Time Factors; Trifluoroacetic Acid; Vaccines, Synthetic | 2014 |
Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice.
Topics: Acetates; Animals; Bacteroides; Bifidobacterium; Cachexia; Cecum; Cells, Cultured; Dietary Supplements; Disease Progression; Gastrointestinal Microbiome; Inulin; Leukemia; Liver; Male; Mice; Mice, Inbred BALB C; Microbiota; Neoplasm Invasiveness; Oligosaccharides; RNA, Ribosomal, 16S | 2015 |
Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Topics: Acetates; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Humans; Polyamines; Sevelamer | 2008 |
Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model.
Topics: Acetates; Animals; Atherosclerosis; Atorvastatin; Carotid Arteries; Catheterization; Chemokine CCL2; Cyclopropanes; Diet, Atherogenic; Disease Progression; Heptanoic Acids; Immunohistochemistry; Leukotriene Antagonists; Lipids; Male; Pyrroles; Quinolines; Rabbits; Random Allocation; Sulfides | 2009 |
Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Cell Proliferation; Disease Progression; Down-Regulation; Ethylamines; Macrophages; Male; Mice; Neuritis, Autoimmune, Experimental; Rats; Receptors, Glucocorticoid; Salsola; T-Lymphocytes, Regulatory; Tyramine; Up-Regulation | 2009 |
PSA decrease with fulvestrant acetate in a hormone-resistant metastatic prostate cancer patient.
Topics: Acetates; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Compassionate Use Trials; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Drugs, Investigational; Estradiol; Fulvestrant; Humans; Injections, Intramuscular; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Retreatment | 2010 |
Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?
Topics: Acetates; Blood Vessels; Calcinosis; Calcium Compounds; Chelating Agents; Disease Progression; Humans; Hyperphosphatemia; Lanthanum; Phosphate-Binding Proteins; Phosphates; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2012 |
Astrocyte metabolism is disturbed in the early development of experimental hydrocephalus.
Topics: Acetates; Animals; Astrocytes; Biomarkers; Brain Stem; Carbon Isotopes; Disease Models, Animal; Disease Progression; gamma-Aminobutyric Acid; Glucose; Glutamic Acid; Glutamine; Hydrocephalus; Kaolin; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Neurotransmitter Agents; Predictive Value of Tests; Rats; Rats, Sprague-Dawley; Taurine; Telencephalon | 2003 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |
Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activity.
Topics: Acetates; Animals; Anterior Cruciate Ligament; Cartilage, Articular; Collagenases; Disease Models, Animal; Disease Progression; Dogs; Enzyme Inhibitors; Metalloproteases; Osteoarthritis, Knee; Pyrroles; Stifle | 2006 |
Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
Topics: Acetamides; Acetates; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Regression Analysis; Sulfonamides; Sulfonic Acids; Total Lung Capacity; Ultrasonography, Interventional | 2006 |
Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
Topics: Acetamides; Acetates; Aged; Atherosclerosis; Biomarkers; Cineangiography; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Dyslipidemias; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Ultrasonography, Interventional | 2007 |
Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Topics: Acetates; Aged; Apoptosis; Cell Proliferation; Cyclopropanes; Disease Progression; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Leukotriene Antagonists; Male; Membrane Proteins; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Quinolines; Receptors, Leukotriene; Sulfides; Tumor Cells, Cultured | 2007 |
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Topics: Acetamides; Acetates; Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Atorvastatin; Catheterization; Cholesterol; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Magnetic Resonance Imaging; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Pyrroles; Rabbits; Random Allocation; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids | 2007 |
Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
Topics: Acetates; Amines; Amyotrophic Lateral Sclerosis; Animals; Brain; Cyclohexanecarboxylic Acids; Diet; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Humans; Mice; Mice, Transgenic; Oxidative Stress; Riluzole; Spinal Cord; Superoxide Dismutase; Survival Analysis; Thiazoles; Vitamin E | 1996 |
The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters.
Topics: Acetamides; Acetates; Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cricetinae; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Liver; Male; Reference Values; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Time Factors; Triglycerides | 1998 |
Caries prevention by CO2 laser treatment: dependency on the number of pulses used.
Topics: Acetates; Carbon Dioxide; Dental Caries; Dental Caries Susceptibility; Dental Enamel; Disease Progression; Hardness; Humans; Hydrogen-Ion Concentration; Laser Therapy; Microscopy, Electron, Scanning; Molar; Tooth Demineralization; Tooth Remineralization; Tooth, Unerupted | 1998 |
Diabetes-induced accelerated atherosclerosis in swine.
Topics: Acetates; Animals; Arteriosclerosis; Blood Glucose; Cholesterol; Cholesterol Esters; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Progression; Islets of Langerhans; Lipids; Monocytes; Oleic Acid; Risk Factors; Streptozocin; Swine; Triglycerides | 2001 |